Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: Treatment outcomes and toxicities

Shyamal Patel, Waleed Fouad Mourad, Chengtao Wang, Bhaswant Dhanireddy, Catherine Concert, Magdalena Ryniak, Azita S. Khorsandi, Rania A. Shourbaji, Zujun Li, Bruce Culliney, Rajal Patel, Richard L. Bakst, Theresa Tran, Daniel Shasha, Stimson Schantz, Mark S. Persky, Kenneth S. Hu, Louis B. Harrison

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aim: To evaluate the locoregional control and treatment toxicity of patients with pleomorphic adenoma after resection with close or positive margins followed by postoperative radiation therapy (PORT). Patients and Methods: Between 2002 and 2011, twenty-one patients underwent PORT at the Mount Sinai Beth Israel Medical Center for pleomorphic adenoma of the parotid with close or positive margins. Four out of the 21 patients (19%) had recurrent lesions. The median dose was 57.6 Gy (range 55.8-69.96) delivered at 1.8-2.12 Gy/fraction. Treatment and follow-up data were retrospectively analyzed for locoregional control as well as acute- and late-treatment toxicities. Actuarial survival analysis was also performed. Results: Twelve women and 9 men with a median age of 46 (26-65) at PORT were included in this study. Eighty-one percent of the cohort had positive resection margins while 19% had close margins. At a median follow-up of 92 months, 19/21 patients (90%) had locoregional control. Two patients who failed had primary lesions which recurred locally, and initially had positive margins. The two recurrences occurred at 8 months and 12 months. Acute Radiation Therapy Oncology Group (RTOG) grade 1 and 2 toxicities were experienced by 11 (52%) and 4 (19%) patients, respectively, while 2 (10%) experienced late RTOG grade 1 toxicities. No patients experienced any grade 2-4 late toxicities. Actuarial survival was 100%. Conclusion: PORT for patients with pleomorphic adenoma of the parotid gland after resection with close or positive margins results in excellent locoregional control and low treatment-related morbidity.

Original languageEnglish (US)
Pages (from-to)4247-4252
Number of pages6
JournalAnticancer research
Volume34
Issue number8
StatePublished - Aug 1 2014

Fingerprint

Pleomorphic Adenoma
Radiotherapy
Radiation Oncology
Actuarial Analysis
Parotid Gland
Israel
Therapeutics
Survival Analysis
Morbidity
Recurrence
Survival

Keywords

  • Benign
  • Close margins
  • Local control
  • Parotid
  • Pleomorphic adenoma
  • Positive margins
  • Postoperative radiation
  • Postoperative radiotherapy
  • Radiation toxicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Patel, S., Mourad, W. F., Wang, C., Dhanireddy, B., Concert, C., Ryniak, M., ... Harrison, L. B. (2014). Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: Treatment outcomes and toxicities. Anticancer research, 34(8), 4247-4252.

Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins : Treatment outcomes and toxicities. / Patel, Shyamal; Mourad, Waleed Fouad; Wang, Chengtao; Dhanireddy, Bhaswant; Concert, Catherine; Ryniak, Magdalena; Khorsandi, Azita S.; Shourbaji, Rania A.; Li, Zujun; Culliney, Bruce; Patel, Rajal; Bakst, Richard L.; Tran, Theresa; Shasha, Daniel; Schantz, Stimson; Persky, Mark S.; Hu, Kenneth S.; Harrison, Louis B.

In: Anticancer research, Vol. 34, No. 8, 01.08.2014, p. 4247-4252.

Research output: Contribution to journalArticle

Patel, S, Mourad, WF, Wang, C, Dhanireddy, B, Concert, C, Ryniak, M, Khorsandi, AS, Shourbaji, RA, Li, Z, Culliney, B, Patel, R, Bakst, RL, Tran, T, Shasha, D, Schantz, S, Persky, MS, Hu, KS & Harrison, LB 2014, 'Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: Treatment outcomes and toxicities', Anticancer research, vol. 34, no. 8, pp. 4247-4252.
Patel S, Mourad WF, Wang C, Dhanireddy B, Concert C, Ryniak M et al. Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: Treatment outcomes and toxicities. Anticancer research. 2014 Aug 1;34(8):4247-4252.
Patel, Shyamal ; Mourad, Waleed Fouad ; Wang, Chengtao ; Dhanireddy, Bhaswant ; Concert, Catherine ; Ryniak, Magdalena ; Khorsandi, Azita S. ; Shourbaji, Rania A. ; Li, Zujun ; Culliney, Bruce ; Patel, Rajal ; Bakst, Richard L. ; Tran, Theresa ; Shasha, Daniel ; Schantz, Stimson ; Persky, Mark S. ; Hu, Kenneth S. ; Harrison, Louis B. / Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins : Treatment outcomes and toxicities. In: Anticancer research. 2014 ; Vol. 34, No. 8. pp. 4247-4252.
@article{8febebeac92b4a4498563a52dcf71e66,
title = "Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: Treatment outcomes and toxicities",
abstract = "Aim: To evaluate the locoregional control and treatment toxicity of patients with pleomorphic adenoma after resection with close or positive margins followed by postoperative radiation therapy (PORT). Patients and Methods: Between 2002 and 2011, twenty-one patients underwent PORT at the Mount Sinai Beth Israel Medical Center for pleomorphic adenoma of the parotid with close or positive margins. Four out of the 21 patients (19{\%}) had recurrent lesions. The median dose was 57.6 Gy (range 55.8-69.96) delivered at 1.8-2.12 Gy/fraction. Treatment and follow-up data were retrospectively analyzed for locoregional control as well as acute- and late-treatment toxicities. Actuarial survival analysis was also performed. Results: Twelve women and 9 men with a median age of 46 (26-65) at PORT were included in this study. Eighty-one percent of the cohort had positive resection margins while 19{\%} had close margins. At a median follow-up of 92 months, 19/21 patients (90{\%}) had locoregional control. Two patients who failed had primary lesions which recurred locally, and initially had positive margins. The two recurrences occurred at 8 months and 12 months. Acute Radiation Therapy Oncology Group (RTOG) grade 1 and 2 toxicities were experienced by 11 (52{\%}) and 4 (19{\%}) patients, respectively, while 2 (10{\%}) experienced late RTOG grade 1 toxicities. No patients experienced any grade 2-4 late toxicities. Actuarial survival was 100{\%}. Conclusion: PORT for patients with pleomorphic adenoma of the parotid gland after resection with close or positive margins results in excellent locoregional control and low treatment-related morbidity.",
keywords = "Benign, Close margins, Local control, Parotid, Pleomorphic adenoma, Positive margins, Postoperative radiation, Postoperative radiotherapy, Radiation toxicity",
author = "Shyamal Patel and Mourad, {Waleed Fouad} and Chengtao Wang and Bhaswant Dhanireddy and Catherine Concert and Magdalena Ryniak and Khorsandi, {Azita S.} and Shourbaji, {Rania A.} and Zujun Li and Bruce Culliney and Rajal Patel and Bakst, {Richard L.} and Theresa Tran and Daniel Shasha and Stimson Schantz and Persky, {Mark S.} and Hu, {Kenneth S.} and Harrison, {Louis B.}",
year = "2014",
month = "8",
day = "1",
language = "English (US)",
volume = "34",
pages = "4247--4252",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "8",

}

TY - JOUR

T1 - Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins

T2 - Treatment outcomes and toxicities

AU - Patel, Shyamal

AU - Mourad, Waleed Fouad

AU - Wang, Chengtao

AU - Dhanireddy, Bhaswant

AU - Concert, Catherine

AU - Ryniak, Magdalena

AU - Khorsandi, Azita S.

AU - Shourbaji, Rania A.

AU - Li, Zujun

AU - Culliney, Bruce

AU - Patel, Rajal

AU - Bakst, Richard L.

AU - Tran, Theresa

AU - Shasha, Daniel

AU - Schantz, Stimson

AU - Persky, Mark S.

AU - Hu, Kenneth S.

AU - Harrison, Louis B.

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Aim: To evaluate the locoregional control and treatment toxicity of patients with pleomorphic adenoma after resection with close or positive margins followed by postoperative radiation therapy (PORT). Patients and Methods: Between 2002 and 2011, twenty-one patients underwent PORT at the Mount Sinai Beth Israel Medical Center for pleomorphic adenoma of the parotid with close or positive margins. Four out of the 21 patients (19%) had recurrent lesions. The median dose was 57.6 Gy (range 55.8-69.96) delivered at 1.8-2.12 Gy/fraction. Treatment and follow-up data were retrospectively analyzed for locoregional control as well as acute- and late-treatment toxicities. Actuarial survival analysis was also performed. Results: Twelve women and 9 men with a median age of 46 (26-65) at PORT were included in this study. Eighty-one percent of the cohort had positive resection margins while 19% had close margins. At a median follow-up of 92 months, 19/21 patients (90%) had locoregional control. Two patients who failed had primary lesions which recurred locally, and initially had positive margins. The two recurrences occurred at 8 months and 12 months. Acute Radiation Therapy Oncology Group (RTOG) grade 1 and 2 toxicities were experienced by 11 (52%) and 4 (19%) patients, respectively, while 2 (10%) experienced late RTOG grade 1 toxicities. No patients experienced any grade 2-4 late toxicities. Actuarial survival was 100%. Conclusion: PORT for patients with pleomorphic adenoma of the parotid gland after resection with close or positive margins results in excellent locoregional control and low treatment-related morbidity.

AB - Aim: To evaluate the locoregional control and treatment toxicity of patients with pleomorphic adenoma after resection with close or positive margins followed by postoperative radiation therapy (PORT). Patients and Methods: Between 2002 and 2011, twenty-one patients underwent PORT at the Mount Sinai Beth Israel Medical Center for pleomorphic adenoma of the parotid with close or positive margins. Four out of the 21 patients (19%) had recurrent lesions. The median dose was 57.6 Gy (range 55.8-69.96) delivered at 1.8-2.12 Gy/fraction. Treatment and follow-up data were retrospectively analyzed for locoregional control as well as acute- and late-treatment toxicities. Actuarial survival analysis was also performed. Results: Twelve women and 9 men with a median age of 46 (26-65) at PORT were included in this study. Eighty-one percent of the cohort had positive resection margins while 19% had close margins. At a median follow-up of 92 months, 19/21 patients (90%) had locoregional control. Two patients who failed had primary lesions which recurred locally, and initially had positive margins. The two recurrences occurred at 8 months and 12 months. Acute Radiation Therapy Oncology Group (RTOG) grade 1 and 2 toxicities were experienced by 11 (52%) and 4 (19%) patients, respectively, while 2 (10%) experienced late RTOG grade 1 toxicities. No patients experienced any grade 2-4 late toxicities. Actuarial survival was 100%. Conclusion: PORT for patients with pleomorphic adenoma of the parotid gland after resection with close or positive margins results in excellent locoregional control and low treatment-related morbidity.

KW - Benign

KW - Close margins

KW - Local control

KW - Parotid

KW - Pleomorphic adenoma

KW - Positive margins

KW - Postoperative radiation

KW - Postoperative radiotherapy

KW - Radiation toxicity

UR - http://www.scopus.com/inward/record.url?scp=84909942462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909942462&partnerID=8YFLogxK

M3 - Article

C2 - 25075054

AN - SCOPUS:84909942462

VL - 34

SP - 4247

EP - 4252

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 8

ER -